Related Experiment Video
Updated: Apr 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies
1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, United States.
Abstract:
Research in cancer biology has been largely driven by experimental approaches whereby discreet inputs are used to assess discreet outputs, for example, gene-knockouts to assess cancer occurrence. However, cancer hallmarks are only rarely, if ever, exclusively dependent on discreet regulatory processes. Rather, cancer-related regulatory factors affect multiple cancer hallmarks. Thus, novel approaches and paradigms are needed for further advances. Signal pathway persistence and amplification, rather than signal pathway activation resulting from an on/off switch, represent emerging paradigms for cancer research, closely related to developmental regulatory paradigms. In this review, we address both mechanisms and effects of signal pathway persistence and amplification in cancer settings; and address the possibility that hyper-activation of pro-proliferative signal pathways in certain cancer settings could be exploited for therapy.
Insights
Cancer research needs new paradigms beyond simple on/off switches. This review explores signal pathway persistence and amplification in cancer, suggesting therapeutic potential for exploiting hyper-activated pathways.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Developmental Biology
Background:
- Traditional cancer research often uses reductionist approaches (e.g., gene knockouts) to study discreet inputs and outputs.
- Cancer hallmarks are complex and rarely depend on isolated regulatory processes; instead, regulatory factors impact multiple hallmarks.
- Existing paradigms may not fully capture the complexity of cancer regulatory networks.
Purpose of the Study:
- To review mechanisms and effects of signal pathway persistence and amplification in cancer.
- To explore the relationship between developmental regulatory paradigms and cancer signaling.
- To investigate the therapeutic potential of exploiting hyper-activated pro-proliferative pathways in cancer.
Main Methods:
- Literature review focusing on signal pathway persistence and amplification.
- Analysis of emerging paradigms in cancer research.
- Exploration of developmental biology principles in cancer contexts.
Main Results:
- Signal pathway persistence and amplification are emerging as key concepts in cancer research, distinct from simple on/off activation.
- These persistent and amplified pathways are closely related to developmental regulatory mechanisms.
- Hyper-activation of pro-proliferative signal pathways presents potential therapeutic targets.
Conclusions:
- Novel approaches focusing on signal pathway dynamics (persistence, amplification) are crucial for advancing cancer biology.
- Understanding these dynamic processes, linked to development, offers new insights into cancer hallmarks.
- Targeting hyper-activated pro-proliferative pathways holds promise for future cancer therapies.
More Related Videos
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

